Casdin Capital as of June 30, 2024
Portfolio Holdings for Casdin Capital
Casdin Capital holds 38 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biolife Solutions Com New (BLFS) | 14.3 | $187M | 8.7M | 21.43 | |
| Revolution Medicines (RVMD) | 13.1 | $171M | 4.4M | 38.81 | |
| Sarepta Therapeutics (SRPT) | 13.0 | $170M | 1.1M | 158.00 | |
| D Fluidigm Corp Del (LAB) | 8.7 | $113M | 64M | 1.77 | |
| Genedx Holdings Corp Com Cl A (WGS) | 7.1 | $92M | 3.5M | 26.14 | |
| Avidity Biosciences Ord (RNA) | 6.5 | $85M | 2.1M | 40.85 | |
| Relay Therapeutics (RLAY) | 4.2 | $55M | 8.4M | 6.52 | |
| Illumina (ILMN) | 3.8 | $50M | 480k | 104.38 | |
| Intellia Therapeutics (NTLA) | 3.4 | $45M | 2.0M | 22.38 | |
| Alnylam Pharmaceuticals (ALNY) | 3.2 | $41M | 170k | 243.00 | |
| Blueprint Medicines (BPMC) | 2.7 | $35M | 326k | 107.78 | |
| Denali Therapeutics (DNLI) | 2.3 | $30M | 1.3M | 23.22 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 2.1 | $28M | 700k | 39.27 | |
| EXACT Sciences Corporation (EXAS) | 2.1 | $28M | 650k | 42.25 | |
| Tenaya Therapeutics (TNYA) | 1.6 | $21M | 6.7M | 3.10 | |
| Neurogene (NGNE) | 1.5 | $19M | 525k | 36.39 | |
| Veracyte (VCYT) | 1.4 | $19M | 858k | 21.67 | |
| 4d Molecular Therapeutics In (FDMT) | 1.3 | $17M | 800k | 20.99 | |
| Beam Therapeutics (BEAM) | 1.2 | $16M | 675k | 23.43 | |
| Verve Therapeutics (VERV) | 1.1 | $15M | 3.1M | 4.88 | |
| Pliant Therapeutics (PLRX) | 0.8 | $11M | 1.0M | 10.75 | |
| Tango Therapeutics (TNGX) | 0.8 | $10M | 1.2M | 8.58 | |
| Century Therapeutics (IPSC) | 0.6 | $8.2M | 3.2M | 2.55 | |
| 2seventy Bio Common Stock | 0.6 | $7.7M | 2.0M | 3.85 | |
| Codexis (CDXS) | 0.5 | $6.2M | 2.0M | 3.10 | |
| Contineum Therapeutics Cl A (CTNM) | 0.4 | $5.2M | 297k | 17.61 | |
| Kyverna Therapeutics (KYTX) | 0.3 | $4.3M | 575k | 7.50 | |
| Syndax Pharmaceuticals (SNDX) | 0.2 | $3.1M | 150k | 20.53 | |
| Absci Corp (ABSI) | 0.2 | $3.0M | 973k | 3.08 | |
| Guardant Health (GH) | 0.2 | $2.9M | 100k | 28.88 | |
| Prime Medicine (PRME) | 0.1 | $1.9M | 367k | 5.14 | |
| Pacific Biosciences of California (PACB) | 0.1 | $1.4M | 1.0M | 1.37 | |
| Grail (GRAL) | 0.1 | $1.2M | 80k | 15.37 | |
| Exscientia Ads (EXAI) | 0.1 | $1.1M | 214k | 5.10 | |
| Monte Rosa Therapeutics (GLUE) | 0.1 | $976k | 261k | 3.74 | |
| Ginkgo Bioworks Holdings Cl A Shs | 0.0 | $488k | 1.5M | 0.33 | |
| Singular Genomics Systems In Com New | 0.0 | $373k | 44k | 8.45 | |
| Kronos Bio | 0.0 | $154k | 124k | 1.24 |
